Type 2 Diabetes in NYC: A Functional and Regenerative Medicine Approach to Root-Cause Treatment

Conventional diabetes management focuses primarily on one endpoint: blood sugar control. Medications are titrated to hit HbA1c targets, and patients are told to exercise and eat less. But for the 37 million Americans living with type 2 diabetes — and the 96 million with prediabetes — this approach often fails to address the underlying drivers of the disease or meaningfully reverse its progression.

At Regen Health Physicians NYC, Dr. Ajit Dhaliwal takes a fundamentally different approach. Rather than managing diabetes as an isolated blood sugar problem, RHPNY treats it as a metabolic systems failure with identifiable, addressable root causes — including insulin resistance, chronic inflammation, gut dysbiosis, hormonal imbalance, and cellular energy dysfunction.

Understanding Type 2 Diabetes Beyond Blood Sugar

Type 2 diabetes develops over years or decades, typically progressing through stages:

1. Insulin resistance: Cells (primarily muscle, liver, and fat) become less responsive to insulin. The pancreas compensates by producing more insulin — a stage of hyperinsulinemia that is often asymptomatic
2. Compensated glucose intolerance: Blood sugar begins rising above normal ranges (prediabetes: fasting glucose 100–125 mg/dL; HbA1c 5.7–6.4%)
3. Overt type 2 diabetes: Fasting glucose ≥126 mg/dL; HbA1c ≥6.5%; the pancreas can no longer compensate for insulin resistance

The conventional framework waits until stage 3 before aggressive intervention. RHPNY works with patients across all stages — with the most powerful opportunities for reversal in stages 1 and 2.

Root Causes of Type 2 Diabetes

A functional medicine lens identifies multiple converging drivers of insulin resistance and metabolic dysfunction:

Chronic Inflammation

Visceral adipose tissue (belly fat) releases pro-inflammatory cytokines (TNF-α, IL-6, MCP-1) that directly impair insulin receptor signaling in muscle and liver cells. Chronic low-grade inflammation — also driven by poor gut health, sleep deprivation, and environmental toxins — is both a cause and consequence of insulin resistance.

Gut Dysbiosis

The gut microbiome plays a critical role in metabolic health. Dysbiosis — an imbalance of beneficial versus harmful gut bacteria — promotes intestinal permeability ("leaky gut"), bacterial endotoxin (LPS) translocation into the bloodstream, and systemic inflammation that impairs insulin signaling. Specific microbial profiles have been associated with both obesity and type 2 diabetes in human studies.

Mitochondrial Dysfunction

Insulin-sensitive cells depend on healthy mitochondria to properly metabolize glucose. Mitochondrial dysfunction — driven by oxidative stress, nutrient deficiencies (CoQ10, B vitamins, magnesium, NAD+), and sedentary behavior — contributes directly to insulin resistance at the cellular level.

Hormonal Imbalance

Several hormonal disruptions accelerate metabolic decline:

• Low testosterone in men (testosterone and insulin resistance are bidirectionally linked)
• Estrogen imbalance in women during perimenopause
• Cortisol elevation from chronic stress (stimulates hepatic glucose production)
• Thyroid dysfunction (hypothyroidism reduces insulin sensitivity and basal metabolic rate)
• Adiponectin deficiency (low levels associated with central obesity and insulin resistance)

Nutritional Deficiencies

Magnesium, vitamin D, zinc, chromium, alpha-lipoic acid, and B vitamins all play direct roles in insulin signaling and glucose metabolism. Deficiencies — common in patients consuming processed diets — contribute to insulin resistance and impair the body's capacity to reverse it.

RHPNY's Integrative Type 2 Diabetes Protocol

Dr. Dhaliwal's approach to metabolic disease begins with comprehensive assessment and moves through structured, evidence-based interventions:

Comprehensive Diagnostic Panel

Beyond standard HbA1c and fasting glucose, RHPNY evaluates:

• Fasting insulin and HOMA-IR (insulin resistance index)
• C-peptide (pancreatic reserve)
• Advanced lipid panel (LDL particle size, ApoB, Lp(a))
• Inflammatory markers (hs-CRP, IL-6, fibrinogen)
• Gut health assessment
• Full hormonal panel
• Nutritional status markers
• Continuous glucose monitor data (often recommended for initial assessment)

Metabolic Nutrition Program

RHPNY's dietary approach is individualized rather than prescriptive, but is informed by:

• Time-restricted eating (TRE): Strong evidence for improving insulin sensitivity without caloric counting
• Low-glycemic, anti-inflammatory nutrition: Reduces post-meal glucose spikes and systemic inflammation
• Personalized macronutrient targets: Based on insulin resistance severity, body composition, and patient preference

Peptide Therapy for Metabolic Health

Peptide therapy is an increasingly important component of metabolic medicine at RHPNY:

• Semaglutide/tirzepatide: GLP-1 and dual GIP/GLP-1 agonists that reduce appetite, improve insulin sensitivity, and produce meaningful weight loss — often enabling reduction or discontinuation of other diabetes medications
• BPC-157: Reduces gut inflammation and supports gut healing, addressing the gut-metabolic axis
• Sermorelin/CJC-1295: Support growth hormone secretion, which improves insulin sensitivity and body composition

Hormonal Optimization

For men with low testosterone or women in perimenopause/menopause, hormone optimization is a foundational component of metabolic treatment. Restoring testosterone in men with hypogonadism has been shown to significantly improve HbA1c and insulin sensitivity.

Mitochondrial Support

RHPNY uses targeted interventions to restore mitochondrial function:

• NAD+ infusion therapy to replenish cellular energy currency
• CoQ10 and alpha-lipoic acid supplementation protocols
• Resistance exercise prescription for mitochondrial biogenesis

Chronic Disease Management

RHPNY integrates these interventions within a comprehensive chronic disease management framework that includes ongoing monitoring, quarterly lab review, and protocol adjustment as the patient progresses.

Is Type 2 Diabetes Reversible?

For patients in the early stages of insulin resistance or prediabetes, metabolic reversal is achievable — not just management. Studies show that significant weight loss (10–15% of body weight), combined with dietary and lifestyle change, can produce complete normalization of blood sugar in a substantial proportion of patients.

Even for patients with established type 2 diabetes of shorter duration, meaningful improvement in HbA1c (often reducing or eliminating medication requirements) is a realistic goal with a comprehensive functional medicine approach.

Book a consultation with Dr. Dhaliwal at RHPNY to begin a thorough evaluation of your metabolic health. To learn more about our chronic disease management programs and how peptide therapy supports metabolic health, explore our service pages.

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Type 2 diabetes is a serious medical condition requiring physician-supervised management. Do not discontinue or adjust diabetes medications without medical supervision. Please consult with a qualified healthcare provider before making changes to your diabetes treatment plan.